Posted in | News | Graphene | Nanobusiness

Carbon Sciences Enters JV to Launch Transphene

Carbon Sciences Inc., focused on the development of a breakthrough technology to mass-produce graphene, the new miracle material, today announced that the company and Dr. Kaustav Banerjee have jointly launched Transphene, Inc., a new graphene venture.

Dr. Banerjee, a leading expert in the field, currently leads a research project at the University of California, Santa Barbara (UCSB), sponsored by Carbon Sciences, to develop a new and scalable graphene synthesis technology. He will serve as Chief Technology Officer of Transphene, Inc.

"We are very excited about our new venture with Dr. Banerjee," said Bill Beifuss, Carbon Sciences' CEO. "Transphene, Inc. will concentrate on the commercial development of a breakthrough technology to mass-produce graphene, and will hold certain intellectual property required to protect these assets in the commercial marketplace."

Graphene, a sheet of pure carbon that is only one atom thick, is flexible, transparent, impermeable to moisture, stronger than diamonds and more conductive than gold. Experts believe graphene to be the miracle material that will enable revolutionary applications such as bendable touch screen displays, rapid charge batteries, super-capacitors, low cost solar cells, extreme high-speed semiconductors, biosensors, as well as water purification.

"Graphene is truly a revolutionary material," said Dr. Banerjee. "Now that we understand its properties, the new challenge is to find a low cost way to mass produce it. Our approach at Transphene is to fine-tune the manufacturing process to match specific applications. We plan to initially target those applications that will most likely find early commercial success."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.